← Product Code [HIN](/submissions/OB/subpart-e%E2%80%94obstetrical-and-gynecological-surgical-devices/HIN) · K122605 # PKS BILL (K122605) _Gyrus Acmi, Inc. · HIN · Dec 5, 2012 · Obstetrics/Gynecology · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OB/subpart-e%E2%80%94obstetrical-and-gynecological-surgical-devices/HIN/K122605 ## Device Facts - **Applicant:** Gyrus Acmi, Inc. - **Product Code:** [HIN](/submissions/OB/subpart-e%E2%80%94obstetrical-and-gynecological-surgical-devices/HIN.md) - **Decision Date:** Dec 5, 2012 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 884.4150 - **Device Class:** Class 2 - **Review Panel:** Obstetrics/Gynecology - **Attributes:** Therapeutic ## Indications for Use The PKS™ (Plasmakinetic System) BiLL™ (Bipolar Laparoscopic Loop) instrument is a 5mm bipolar electrosurgical device. The device is intended to be used for the amputation of the mobilised uterus during Laparoscopic Supracervical (Subtotal) Hysterectomy and the resection of devascularized subserosal pedunculated myomas. It is used in conjunction with the Gyrus ACMI G400 Workstation Generator. ## Device Story 5mm bipolar electrosurgical instrument; used for uterine amputation during laparoscopic supracervical hysterectomy and resection of pedunculated myomas. Operates with Gyrus ACMI G400 Workstation Generator; utilizes Bipolar PK (Plasma Kinetic) technology. Device includes identification capacitor in connector cable to communicate optimal power parameters to generator. Single-use, sterile, gamma-irradiated. Operated by physicians in surgical settings. Provides electrosurgical cutting/coagulation via high-frequency RF energy. Benefits include efficient tissue resection and hemostasis during minimally invasive gynecological procedures. ## Clinical Evidence No clinical data. Pre-clinical evaluation performed using extirpated human uterine tissue with three physicians conducting mock procedures. Qualitative feedback confirmed device met performance expectations and user needs. Bench testing included design verification, validation, and electrical safety testing per IEC 60601. Biocompatibility testing passed per ISO-10993-1. ## Technological Characteristics 5mm bipolar electrosurgical loop; high-frequency RF energy source. Uses identification capacitor for generator communication. Compliant with IEC 60601 (electrical/thermal safety, EMI). Biocompatible materials per ISO-10993. Sterile, single-use, gamma-irradiated. ## Regulatory Identification A bipolar endoscopic coagulator-cutter is a device used to perform female sterilization and other operative procedures under endoscopic observation. It destroys tissue with high temperatures by directing a high frequency electrical current through tissue between two electrical contacts of a probe. This generic type of device may include the following accessories: an electrical generator, probes, and electrical cables. ## Special Controls *Classification.* Class II. The special controls for this device are:(1) FDA's: (i) “Use of International Standard ISO 10993 ‘Biological Evaluation of Medical Devices—Part I: Evaluation and Testing,’ ” (ii) “510(k) Sterility Review Guidance 2/12/90 (K-90),” and (iii) “Guidance (‘Guidelines’) for Evaluation of Laproscopic Bipolar and Thermal Coagulators (and Accessories),” (2) International Electrotechnical Commission's IEC 60601-1-AM2 (1995-03), Amendment 2, “Medical Electrical Equipment—Part 1: General Requirements for Safety,” (3) American National Standards Institute/American Association for Medical Instrumentation's HF-18, 1993, “Electrosurgical Devices,” (4) Labeling: (i) Indication: For female tubal sterilization, and (ii) Instructions for use: (A) Destroy at least 2 centimeters of the fallopian tubes, (B) Use a cut or undampened sinusoidal waveform, (C) Use a minimum power of 25 watts, and (D) For devices with ammeters: continue electrode activation for 5 seconds after the visual endpoint (tissue blanching) is reached or current flow ceases indicating adequate tissue destruction. ## Predicate Devices - Gyrus ACMI PKS™ BiLL™ ([K111059](/device/K111059.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Olympus Surgical Technologies of America · Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772 | 510(K) SUMMARY | |----------------| |----------------| PKS" BiLL"" General Information Manufacturer: 510(k) Submitter: Contact Person: Date Prepared: Classification Name: Trade Name: Generic/Common Name: Bipolar Loop / Bipolar Laparoscopic Loop Predicate Device Gyrus ACMI PKS™ BiLLTM K11059 Indications for Use The PKS™ (Plasmakinetic System) BiLL™ (Bipolar Laparoscopic Loop) instrument is a 5mm bipolar electrosurgical device. The device is intended to be used for the amputation of the mobilised uterus during Laparoscopic Supracervical (Subtotal) Hysterectomy and the resection of devascularized subserosal pedunculated myomas. It is used in conjunction with the Gyrus ACMI G400 Workstation Generator. Product Description The Bipolar Laparoscopic Loop is a single use disposable high frequency RF bipolar accessory to be used in conjunction with the G400 generator. It is available in an 88mm x 227mm loop size. The device is sterile for single use sterilized by gamma irradiation to an SAL of 10-6. Page 10 Special 510(k) Notifi DEC 0 5 2012 Special 510(k) Notification (508) 804-2690 neil.kelly@Olympus-OSTA.com Neil Kelly Gyrus Medical, Ltd. Fortran Road, St. Mellons Cardiff CF3 OLT ERN: 9617070 Gyrus ACMI Inc. 136 Turnpike Rd. ERN: 3003790304 Southborough, MA 01772-2104 August 24, 2012 Coagulator-Cutter, Endoscopic, Bipolar (And Accessories) Obstetrics/Gynecology HIN 21 CFR 884.4150 Class II PKSTM BILLTM BiLap Loop / Bipolar Laparoscopic Loop {1}------------------------------------------------ Olympus Surgical Technologies of America Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772 # Performance Data Technological features and Substantial Equivalence The PK STM BiLL™ utilizes features incorporated into the following legally marketed predicate device: - The bipolar PKS™ BiLL™ connects to the same electrosurgical generator, G400 . (K050550) as the predicate PKSTM BiLLTM (K111059). - The PKSTM BiLL™ uses Bipolar PK (Plasma Kinetic) technology and contains . an identification capacitor embedded in the single use connector cable will be recognized by the generator to set default optimal power output parameters for the subject instrument. This remained unchanged and identical to the predicate PKS™ BiLLTM (K111059). - . The mechanical design features of the PKS™ BiLL™ are similar to that of the predicate PKSTM BiLLTM (K111059). The proposed PKS™ BiLL™ has the identical Indications for use as the predicate PKSTM BiLLTM. The PKS™ BiLLTM instrument is compliant to electrical standards specifically to those applicable sections of IEC 60601 incorporating electrical, thermal safety and Electromagnetic Interference. . The PKSTM BiLLTM instrument uses materials that are well established and used in other GYRUS ACMI FDA cleared medical devices. Biocompatibility testing on all patient contacting parts has been performed in compliance to the relevant requirements of ISO-10993. The PKS™ BiLL™ instrument is packaged and sterilized as a sterile single use device. #### Bench, Biocompatibility, and General Safety Summary Design verification testing was carried out to ensure the device meets the product specifications, and design validation was carried out to ensure the product meets the user requirements. All testing was completed successfully. Electrical testing was also carried out to IEC 60601 and passed as well. In addition the representative final product was tested to and passed ISO-10993-1. The product has been determined to be biocompatible. #### Pre-clinical Evaluation Summary In addition a pre-clinical evaluation was carried out using extirpated tissue (Human Uterine), and three (3) Physicians. Thirty-two (32) questions were asked of each of the three physicians after they carried out a mock procedure using the proposed device. These questions ranged from ease of understanding the IFU, to performance related questions specific to the {2}------------------------------------------------ Olympus Surgical Technologies of Američa Gyrus ACMI, Inc. 136 Turnpike Road Southborough, MA 01772 procedure. All three physicians were happy with the proposed device and felt it met their needs and performed to their expectations. ﺎ ## Summary The proposed Gyrus ACMI Inc. Bipolar Laparoscopic Loop (PKS™ BiLL™), as described in this submission, is substantially equivalent to the predicate in intended use, materials, principles of operation and fundamental scientific technology and raises no new issues of safety and effectiveness. {3}------------------------------------------------ Image /page/3/Picture/0 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three curved lines that resemble a person embracing another person. # DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002 December 5, 2012 Gyrus ACMI, Inc. % Mr. Neil Kelly Regulatory Affairs Specialist 136 Turnpike Road SOUTHBOROUGH MA 01772 Re: K122605 Trade/Device Name: Gyrus ACMI® Bipolar Laparoscopic Loop (PKSTM BILLTM) Regulation Number: 21 CFR§ 884.4150 Regulation Name: Bipolar endoscopic coagulator-cutter and accessories Regulatory Class: II Product Code: HIN Dated: November 2, 2012 Received: November 5, 2012 Dear Mr. Kelly: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. {4}------------------------------------------------ Page 2 - Mr. Neil Kelly You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours. **Herbert** R. **Lerner** for Benjamin R. Fisher, Ph.D. Director Division of Reproductive, Gastro-Renal, and Urological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {5}------------------------------------------------ ### Indications for Use Statement 510(k) Number: : K122605 Device Name: Gyrus ACMI® Bipolar Laparoscopic Loop (PKS™ BiLL™) Indications for Use: The PKS™ (Plasmakinetic System) BiLL™ (Bipolar Laparoscopic Loop) instrument is a 5mm bipolar electrosurgical device. The device is intended to be used for the amputation of the mobilised uterus during Laparoscopic Supracervical (Subtotal) Hysterectomy and the resection of devascularized subserosal pedunculated myomas. It is used in conjunction with the Gyrus ACMI G400 Workstation Generator. Prescription Use: X OR Over-the-Counter Use: (Per 21 CFR 801.109) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) **Herbert P. Lerner** | (Division Sign-Off) | | |---------------------------------------------|--------| | Division of Reproductive, Gastro-Renal, and | | | Urological Devices | | | 510(k) Number | K22605 | --- **Source:** [https://fda.innolitics.com/submissions/OB/subpart-e%E2%80%94obstetrical-and-gynecological-surgical-devices/HIN/K122605](https://fda.innolitics.com/submissions/OB/subpart-e%E2%80%94obstetrical-and-gynecological-surgical-devices/HIN/K122605) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com